2021
Race and ethnicity do not impact eligibility for remdesivir: A single-center experience
Pischel L, Walelo M, Benson J, Osborn R, Schrier R, Tuan J, Barakat L, Ogbuagu O. Race and ethnicity do not impact eligibility for remdesivir: A single-center experience. PLOS ONE 2021, 16: e0250735. PMID: 33956849, PMCID: PMC8101938, DOI: 10.1371/journal.pone.0250735.Peer-Reviewed Original ResearchConceptsClinical trialsExclusion criteriaSingle health care systemObservational cohort studySingle-center experienceClinical trial criteriaTime of presentationMedical record chartsNon-Hispanic whitesEthnic minority enrollmentSimilar ratesHealth care systemCohort studyTrial criteriaMultiple therapiesInclusion criteriaRecord chartsEthnic groupsRemdesivirCare systemTrialsSelf-identified WhiteEligibilityWhite participantsMultiple potential barriers
2003
Complicated Left-Sided Native Valve Endocarditis in Adults: Risk Classification for Mortality
Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated Left-Sided Native Valve Endocarditis in Adults: Risk Classification for Mortality. JAMA 2003, 289: 1933-1940. PMID: 12697795, DOI: 10.1001/jama.289.15.1933.Peer-Reviewed Original ResearchConceptsLeft-sided native valve endocarditisNative valve endocarditisPrognostic classification systemsValve endocarditisValidation cohortRetrospective observational cohort studyObservational cohort studyBaseline featuresEstimation of prognosisCause mortalityCohort studyDerivation cohortSignificant morbidityClassification systemPrognostic severityConnecticut hospitalsMAIN OUTCOMESimilar riskEndocarditisMortality rateMortalityCohortPatientsRisk classificationAdults